NCT02648620 - Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 5, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

February 11, 2020

Conditions

Peripheral Arterial DiseasePeripheral Vascular Diseases

Interventions

DEVICE

SurVeil Drug Coated Balloon

Angioplasty procedure with the SurModics SurVeil Paclitaxel-Coated, Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter (Paclitaxel-coated PTA Catheter)

PROCEDURE

Angioplasty

Angioplasty procedure with the SurModics SurVeil Paclitaxel-Coated, Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter (Paclitaxel-coated PTA Catheter)

Trial Locations (3)

27607

NC Heart and Vascular Research, Raleigh

37660

Wellmont Health System, Kingsport

43214

OhioHealth Research Institute, Columbus

All Listed Sponsors

lead

SurModics, Inc.

INDUSTRY